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By the end of this lecture…
1. Bone is a complicated tissue.
2. NASA has constraints: low subject #’s; slow data acquisition.
3. Astronauts are understudied group.
4. Spaceflight effects on bone are unique.
5. Clinically-accepted guidelines not applicable.
6. Widely-applied imaging technology (for Bone Mineral 
Density – BMD) is insufficient fully understanding bone 
changes due to spaceflight exposure.
Given NASA’s constraints for decision-making, 
Bone Discipline is investigating/advocating the 
transition of innovative research technologies to 
support decision-making (mission planning and risk 
management)  and time-efficiency. 

Whether the bone problem is “solved” 
depends upon the stakeholder’s perspective.
1. Program Managers – Have we mitigated risks to astronaut health and 
performance to ensure mission objectives can be accomplished while 
minimizing impact on power/mass/volume/time/expense?
2. Human Risk Board – Does spaceflight increase the probability of fracture 
both during mission operations and long-term health [LTH]? Can we 
ensure that astronauts are working within the operating standards of 
bone health? Is current risk management considered CONTROLLED?
3. Space & Clinical Operations – Do/will the results of proven clinical tests 
substantiate that the bone health of astronauts is impaired and requires 
a clinical response? Do we know what should be the therapeutic 
response?
Whether the bone problem is “solved” 
depends upon uncertainties willing to accept.
5. Bone Biomedical Research: Are we collecting the right data to sufficiently 
assess the probability of fracture during missions (and after return)? To 
assess the causality of IVD/back injury to spaceflight? Do we know which 
risk factors for bone loss/for overloading bones we should target first for 
mitigation? Can we identify which astronauts are at greatest need for 
mitigation?
6. Human Systems Engineering: Can we sufficiently engineer-out hazards 
(e.g., mechanical loads) to the skeleton to prevent injury?
7. Challenge: Not all stake holders are on the same page regarding what is 
an acceptable and controlled risk. (Not understanding Bone physiology).
Skeletal Sites: Different composition of Bone Types 
with different contributions (a GAP) to Bone Integrity
Cortical Bone/ “Compact Bone”
Sources:  L. Mosekilde; SL Bonnick; P Crompton
PROXIMAL FEMUR
VERTEBRAL BODY – 66% BMD
Cancellous “Spongy” Bone/Trabecular Bone
Trochanter
50% BMD
Femoral Neck
25% BMD
Entire skeleton turns-over  
10%/year:  3% cortical bone 
but 25% of cancellous bone
Cortical  Bone 80% of 
total skeleton
(long bones)Cancellous Bone 20% of 
total skeleton (vertebrae,
ribs, ends of long bones)
Contains 80% of bone 
surfaces
Different Distribution and Turnover Rates for 
Bone Types to Support Skeletal Functions
Remodeling of Bone Tissue in Adults is Highly 
Regulated* - Perturbations to Relative Rates can 
Influence Skeletal Integrity
1-2 million Bone Remodeling Units
[BRUs] in the  adult skeleton
*Resorption occurs at faster rate, occurs first, relative to 
formation. Requires communication between cells.
Osteoporosis BF BR
Aging (primary, type II)
-
Disuse* (“Skeletal unloading”)
/-
Glucocorticoids 
*early, transient
*
Menopause (primary, type I)
Alcohol
-
Metabolic diseases of High Bone 
Turnover
Some insight gained by comparison to 
Earth-based disorders of increased bone resorption.
Research Specialties in Bone & Mineral Field
Endocrinology (704)
Cell Biology (637)
Molecular Biology (460)
Orthopaedics (336)
Figure Courtesy of the ASBMR 2014; adapted
Biomechanics (250)
Human Bone Risk: It’s all about fracture.
Applied Load > Bone Strength = FRACTURE
(Key Causality – BIOMECHANICS)
You don’t have to have OSTEOPOROSIS.
“Osteoporotic/Fragility Fractures” –
low to atraumatic Fractures 
due to Osteoporosis
(Causality - SKELETAL CONDITION)
You don’t have to be OLD.
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Riggs BL, Melton LJ:  Adapted from Involutional osteoporosis
Oxford Textbook of Geriatric Medicine
ADAPTED SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
Gain and Loss of Bone Mass in the Aging Human
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FRAGILITY FRACTURES in long-duration [LD] astronauts: Are they 
are risk for premature  low trauma fractures due to prolonged 
exposure to space?
Cooper and Melton, 1992SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
45-70 yr 45-60 yr
Adapted from: Pathogenesis of Osteoporosis-Related Fractures (NOF) Cooper C, Melton LJ
Fracture
Probability
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and
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bone 
loading
Clinical risk factors
High bone 
turnover
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Propensity 
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Certain 
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Bone is a complicated tissue.  Clinicians evaluate the 
multifactorial nature of bone loss and fracture risk for at risk 
patients here on Earth
Lifestyle factors
Genetic factors
Medications
Disorders
 Androgen insensitivity
 Anorexia ervosa and bulemia
 Athletic amnorrhea
 Hyperpr l ctinemia
 Panhypopituitarism
 Cystic fibrosis
 Osteogenesis imperfecta
 Marfan syndrome
 Hemochromato is
 Riley-Day syndrome
 Low calcium intake
 Alcohol (3 or more drinks/d)
 Smoking
 High salt intake
 Immobilization/Reduced physical 
activity 
 Endocrinal
 Gastrointestinal
 Hematologic
 Rheumatic and autoimmunal
 Miscellaneous
 Anticoagulants
 Anticonvulsants
 Barbiturates
 Glucocorticoids
 Cancer chemotherapeutic drugs
Adapted from: Pathogenesis of Osteoporosis-Related Fractures (NOF) Cooper C, Melton LJ
Fracture
Probability
Aging
Hypogonadism
and
Menopause
Excessive 
bone 
loading
Ca/Nutrition/
Vit D/Endocrine 
Perturbations/
Muscle Atrophy
Unbalanced and 
increased bone 
resorption
Inadequate 
peak bone 
mass
Increased 
bone loss
Falling in partial
gravity
Skeletal 
fragility
Impaired 
bone quality
Postural
instability/
Gait impairment
Fall 
Mechanics in hypoG
Hazardous environment/
Kinetic energy
Certain 
Activities
Extravehicular
Activities
Exercise loading
Low bone 
density
Bone loss in space is novel.  While astronauts are not “patients” 
unique operationally-induced* factors in astronauts are possible 
contributors to fracture risk. 
Reduced  activity, 
weightbearing; diet
Family History
Medications
Disorders
CO2; Radiation on bone marrow cells, 
Fluid shifts and regional blood flow
*exposure to space environment and mission operations
     Shuttle 
1981-2010 
     
Mercury 
1961-63 
Gemini 
1965-66 
Apollo 
1968-72 
Skylab 
1973-
74 
 Intl Space Station 
2000-present 
      
       
 
 
 
 Calcium 
balance 
 
SPA of 
heel and 
wrist 
Soyuz/Salyut 
1974-85 
 
 SPA  
 Urine, fecal Ca 
Mir 
1986-2000 
 
 DXA 
 
 
 
 DXA 
 QCT 
 pQCT 
 BTO 
    Heel,Wrist 
   
    
 
Characterizing Bone Changes* in Space
SPA=Single Photon Absorptiometry
DXA=Dual-energy X-ray Absorptiometry
QCT=Quantitative Computed Tomography
pQCT = peripheral QCT 
BTO=biochemical markers of bone turnover
*Two functions of skeleton
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FRAGILITY FRACTURES during LTH: Quantifying # premature  
low trauma fractures in astronauts not practical.
Cooper and Melton, 1992SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
45-70 yr 45-60 yr
Thus, NASA adapted the clinical surrogate for fracture (BMD) 
and WHO guidelines for 1o Osteoporosis for bone health 
standards in long-duration astronauts (Circa 2000) 
T-scores* (Not BMD change). 
Permissible 
Outcome
Limit
Preflight 
“Fit for Duty”
Mitigation
Efficacy
*T-score is # Standard Deviations from mean BMD of young normal “peak bone mass”
Bone Densitometry more than a fracture surrogate 
in ISS Astronauts (MedB 1.11)
• Describe skeletal effects of spaceflight
• Track individual bone loss and recovery after long-duration flights.
• Informs rehabilitation efforts
• Facilitates recertification for long-duration missions 
• For evaluation of in-flight exercise countermeasures and postflight 
rehabilitation processes.
Meanwhile, Terrestrial Observation of Reduced Sensitivity of DXA Test: 
“T-score Osteoporosis” Misses Over 50% of Fragility Fractures”
Only 44% of women (21% of men) who sustain non-vertebral fractures have 
“osteoporosis” by BMD*
Adapted from Schuit, Bone. 
2004;34:195-202. Slide 
from J Shaker, MD; 
ISCD 2015 Annual 
Meeting 
5794 participants in the 
Rotterdam study; 
Mean follow-up 6.8 yrs
FN BMD at baseline
(Female data presented 
here)
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*Also disconnects evident with clinical trials– reduced ability to monitor therapeutic response to pharm agents. 
Addtl shortcoming with BMD Guidelines: Cannot identify high risk 
persons in patients with other patterns of sub-regional bone loss 
(i.e., distinct from bone loss with aging – relevance to spaceflight-
induced changes).
Seeman, JCI 1992
DPA measure of BMD
DXA BMD test/guidelines have limited clinical utility for 
younger-aged astronauts.
Kanis et al JBMR 9(8):1137, 1994
Not likely to lose BMD Not likely to fracture* (hip data only) if they DID lose BMD
* it is the probability of fracture that drives the requirement for interventions, not declines in BMD.
Chemical Composition
Areal BMD
50-70% of bone 
Strength.
Bone Microarchitecture
Remodeling Rate 
Bone
Quality
ECM Properties
Geometry
Mineralization
Osteoporosis is a 
skeletal disorder 
characterized by 
compromised bone 
strength predisposing 
to an increased risk of 
fracture.  Bone 
strength reflects the 
integration of two 
main features: bone 
density and bone 
quality.”  JAMA 2001
Activation Frequency
Microdamage Accumulation
Ultrastructure
Genetic Profile
Loading Conditions
“Bone Quality: What is it and Can we measure it?”
May 2005 
SD Clinical Test: Not clinically applicable to younger-aged 
astronaut population (Bone Summit, 2010). 
What about BMD as a metric for bone 
strength ?
The good, the bad, and the ugly.
Seminal DXA study of Mir Crew Members
Areal BMD 
g/cm2
%/Month 
Change + SD
Lumbar Spine -1.06+0.63*
Femoral Neck -1.15+0.84*
Trochanter -1.56+0.99*
Total Body -0.35+0.25*
Pelvis -1.35+0.54*
Arm -0.04+0.88
Leg -0.34+0.33*
*p<0.01, n=16-18 Leblanc et al, 2000.
Hip
1.5% / month
Whole Body
0.3% / month
Lumbar Spine
1% / month
Declines in bone mass are rapid and site-specific.
vs. 0.5 – 1.0 % BMD loss/yr in the aged
.
QCT estimates fracture loads
better than DXA  R2=.66 QCT
QCT + FEM has superior 
capabilities for estimating fracture 
loads R2 =.84 FEM
R2=.66
QCT
R2 =.57
DXA
R2 =.84
FEMDD Cody:  Femoral strength is better predicted  by finite element 
models than QCT and DXA.  J Biomechanics  32:1013 1999.
In vitro studies : DXA BMD underestimates bone 
strength relative to QCT and QCT-FEM.
DXA 2-D Limitation for BMD as a surrogate for bone strength: BMD 
g/cm2 cannot delineate different sizes (which influences bone strength).
2-d projected areal bone mineral density
(BMD = g/cm 2)
Areal BMD is not a good measurement to 
monitor restoration to or maintenance 
of preflight status.
Adapted figure from M. Bouxsein, PhD 
Presentation, Bone Quality May 2-3, 2005; Bethesda, MD
Literature: Exercise changes geometry/size of whole bone (adult skeleton)-
Suggests DXA not good for monitoring exercise as countermeasure.  (2011)
1. Haapasalo H, Sievanan H, Kannus P, Heinonen A, Oja P, Vuori I.  1996  Dimensions and estimated 
mechanical characteristics of the humerus after long-term tennis loading.  J Bone Miner Res.  
11:864-872.
2. Adami S, Gatto D, Braga V, Bianchini D, Rossini M.  1999  Site-specific effects of strength training 
on bone structure and geometry of ultradistal radius in postmenopausal women.  J Bone Miner 
Res.  14(1):120-124.
3. Haapasalo H, Kontulainen S, Sievanen H, Kannus P, Jarvinen M, Vuori I.  2000  Exercise-induced 
bone gain is due to enlargement in bone size without a change in volumetric bone density: a 
peripheral quantitative computed tomography study of the upper arms of male tennis players.  
Bone  17(3):351-357.
4. Vainionpaa A, Korpelainan R, Sievanen H, Vihriaia E, Leppaluoto J, Jamasa T.  2007  Effect of 
impact exercise and its intensity on bone geometry at weight-bearing tibia and femur.  Bone  
40(3):604-611.  
5. Hind K, Gannon L, Whatley, Cooke C, Truscott J.  2011  Bone cross-sectional geometry in male 
runners, gymnasts, swimmers and non-athletic controls: a hip-structural analysis study.  Eur J 
Appl Physiol .  e pub May 24
29

Bottom Line: Difficult to interpret % change in a DXA BMD over mission because 
cannot delineate bone gains or losses in different bone types.
Additionally, assays for biochemical markers in serum and 
urine suggest trends in cellular activities 
Serum:
Total and bone-specific alkaline phosphatase (formation)
Osteocalcin (formation)
Total serum Calcium (40% protein bound;  calcium complexes)
Ionized serum Calcium (physiologically active)
Urine:
Pyridinium cross-links (resorption)
Deoxypyridinoline cross-links (resorption)
n-telopeptide (resorption)
Hormones:  (regulation of calcium homeostasis)
Parathyroid hormone – glands - main calcium sensing organ
1,25 Dihydroxyvitamin D -- stimulates Ca conservation
25 Hydroxyvitamin D – assayed vitamin D metabolite (substrate)
Urinary calcium excretion (trend same as bone resorption 
markers) help elucidate how countermeasures affect bone cell 
activities Suggests that Exercise does not suppress breakdown 
of bone.
* Significantly different from pre-flight, p < 0.05 
Bone Turnover
Slide Courtesy of Dr. SM Smith; Adapted by Sibonga
Bone Turnover Markers: suggest uncoupling of 
remodeling -- may result in net loss in bone 
mass from skeleton.
Subsequent Pilot Study: 
Hip QCT to monitor response to 
countermeasure.
1. Utility: QCT will distinguish 
the effects of biochemical 
from mechanical 
countermeasures.
2. Important to use QCT to 
evaluate Countermeasures 
that affect different bone 
types (anti-resorptives vs. 
anabolic drugs).
3. Utility: QCT data to estimate 
hip strength to answer “so 
what?” question.
Endocortical bone resorption with disuse
From J.W.Jaworski
Images Courtesy of D Carter, PhD
Fractures
Bone Research Plan
QCT quantifies volumetric BMD
DXA reports areal BMD (aBMD)
Densitometry for Bone Macroarchitecture
g/cm2  averaged for cortical + trabecular bone
g/cm3 for separate  cortical & trabecular bones
Flight Research:  QCT detects different rate of vBMD 
loss in separate bone compartments of hip. (n=16 ISS 
volunteers)
Index 
DXA 
 
%/Month 
Change + SD 
Index 
QCT 
%/Month 
Change + SD  
aBMD Lumbar 
Spine 
1.06+0.63* Integral vBMD 
Lumbar Spine 
 
0.9+0.5 
 
 
 
  Trabecular 
vBMD Lumbar 
Spine 
 
0.7+0.6 
aBMD Femoral 
Neck 
1.15+0.84* Integral vBMD 
Femoral Neck 
 
1.2+0.7 
  Trabecular 
vBMD 
Femoral 
 Neck 
 
2.7+1.9 
aBMD 
Trochanter 
1.56+0.99* Integral vBMD 
Trochanter 
 
1.5+0.9 
*p<0.01,  
n=16-18 
 Trabecular 
vBMD 
Trochanter 
2.2+0.9 
 
LeBlanc, J Musculoskelet Neuronal Interact. 2000 ; 
Lang , J Bone Miner Res, 2004; 
Bone Turnover
Slide Courtesy of Dr. SM Smith; Adapted by Sibonga
Bone Turnover Markers: suggest uncoupling of 
remodeling  -- may result in  net loss in bone 
mass from skeleton.
“Bone Quality: What is 
it and Can we measure 
it?” Bethesda, MD, May 2005 
”The other 30-50%”
Turnover Rate
*Osteoporosis is a skeletal disorder characterized by compromised bone strength predisposing to an increased risk of 
fracture.  Bone strength reflects the integration of two main features: bone density and bone quality.”  JAMA 285(6):785-95, 
2001
Bone Strength (a contributor to fracture risk) is 
affected by factors not detected by DXA BMD. 
3235
QCT in aging populations increases knowledge 
of macroarchitectural changes: Bone loss occurs at 
earlier age than expected. (Rec. from Bone Lead)
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Riggs et al. JBMR19:1945, 2004.
Slide courtesy S. Khosla, adapted by Sibonga
Macroarchitecture of Spine in 8 ISS astronauts of Extension 
Study : Discordant Recovery Patterns After Spaceflight
QCT Extension Study (n=8) Postflight Trabecular BMD in hip.  Carpenter, D et al. Acta Astronautica, 2010.
Adapted by Sibonga
L1-L4 L1, L2
DXA vs. QCT Proximal Femur of Extension Study: 
Clinical Advisory Panel  identifies a clinical trigger for long-duration astronauts. 
“Failure to recover in trabecular BMD by R + 2 years” *
QCT Extension Study (n=8) Postflight Trabecular BMD in hip.  Carpenter, D et al. Acta Astronautica, 2010. 
Adapted by Sibonga. * Orwoll JBMR, 2013
*SD response – seek osteoporosis specialist for evaluation and possible intervention.
QCT measures are independent predictors of hip fracture in addition to aBMD. 
Persistent deficits may combine with age-related changes.
Clinical advisory panel recommends clinical trigger for possible intervention 
(monitor for recovery by two years after return).
How can we assess fracture risk in astronauts from QCT data?
Clinical advisory panel: Explore the emerging data from population studies to propose how Finite 
Element Models of QCT data could be used to reflect fracture risk due to spaceflight. (Report back 
to the clinical advisory panel).
• Male-female differences in prediction of hip fracture during finite element analysis. Keyak JH, Sigurdsson S, 
Karlsdottir G, Oskarsdottir D, Sigmarsdottir A, Zhao S, Kornak J, Harris TB, Sigurdsson G, Jonsson BY, 
Siggeirsdottir K, Eiriksdottir G, Gudnason V, Lang TR. Bone. 2011;48(6):1239-1245.
• Association of hip strength estimates by finite –element analysis with fractures in women and men. Amin 
S,, Kopperdahl DL, Melton LJ 3rd, Achenbach SJ, Therneau TM, Riggs BL, Keaveny TM, Khosla S. J Bone Miner 
Res. 2011;26(7):1593-1600.
• Age-dependence of femoral strength in white women and men. Keaveny TM, Kopperdahl DL, Melton III LJ, 
Hoffmann PF, Amin S, Riggs BL, Khosla S. J Bone Miner Res. 2010;25(5):994-1001.
• Osteoporotic Fractures in Med Study Group. Finite element analysis of the proximal femur and hip fracture 
risk in older men. Orwoll ES, Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, Lane N, 
Hoffmann PR, Kopperdahl DL, Keaveny TM J Bone Miner Res. 2009;24(3):475–483.
• More from the ISCD 2015 position development (22 total for QCT and FEM).
Individual Astronaut Results
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Individual Astronaut Results
Fall Loading (3 gain to 24% loss in strength)
0 2 4 6
Time (months)
H
ip
 S
tr
en
gt
h
 (
kN
)
4.0
3.5
3.0
2.5
2.0
1.5
Max loss
24%
Keyak, et al. Bone 2009
05000
1 10
4
1.5  10
4
2 10
4
2.5  10
4
30 40 50 60 70 80 90 100
All Male Subjects
Stance Loading
AGES Cont rols
Pre-f light
AGES Fract ures
Post -f light
S
ta
n
c
e
 (
N
)
Age (years)
Data slide courtesy of Keyak.  NOT FOR DISTRIBUTIONREPRESENTATIVE POPULATION DATA
The FEM knowledge, gained from population studies – how can it be 
used to support the monitoring of astronaut  bone health?
E. Orwoll MD, S Khosla MD, S Amin MD, T Lang PhD, J Keyak PhD, T Keaveny PhD, D Cody PhD, 
JD Sibonga, Ph.D.
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Data slide courtesy of Keyak.  NOT FOR DISTRIBUTIONREPRESENTATIVE POPULATION DATA
Minimum Permissible
Outcome 
Minimum FE strength 
for Bone Health*
RESEARCH MTL807: Recommendation of FE Operating Bands of “Bone Health”- by 
FE Task Group II - to be used together with DXA BMD Standards to inform 
clinical/operational decision-making.
E. Orwoll MD, S Khosla MD, A Cheung, MD, S Amin MD, T Lang PhD, J Keyak PhD, D Nicolella PhD
T Keaveny PhD,  D Cody PhD, and J Sibonga, PhD
*Red, Yellow  and Green 
Operating Bands for Astronauts – Example Only
*Current PRA using DXA BMD for bone strength is insensitive to BMD 
changes due to ARED or Bisphosphonates.  FE strength reduces 
uncertainty; can be used to individualize risk management.
Additional Goal is to integrate QCT and  FEM hip strength* to assess 
probability of Bone Fracture -- NASA Glenn Research Center’s  
Probabilistic Risk Assessment [PRA] Model for Fracture Likelihood
Bone Changes in 
Space
courses.washington.e
du/me598rc 
Biomechanics and 
Mission Operations
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Figure 2.  Summary of literature survey on fracture load as a function of femoral 
neck BMD 
Clinical and 
Engineering 
Characteristics of 
Bone Strength
Estimate of 
Fracture Probability
Probability of 
Fracture
Probability bone 
will fail to 
support load
Probability of 
event
Slide courtesy of J Myers; Adapted by Sibonga
Bone Microarchitecture
Knowledge and Technology Gap
High Resorption Disrupts Microarchitecture     Fractures*
GAPS persist.
Predisposed to “codfish” fx
Male Astronauts?
Spaceflight Effect?
The Hip?
“plates” TbTh “rods” TbTh
TbN
TbSep
Indices of bone microarchitecture reflect changes in trabeculae size 
and spatial orientation – need to identify non-permissible outcome
Adapted by Sibonga
Monitoring microarchitectural changes: Establish
when perforation may occur. Mechanism of disruption 
informs countermeasure (anti-resorptive or anabolic)
Electron Microscopic Images to demonstrate mechanism of disruption ONLY
Recap
It’s challenging.
Sole use of BMD data as a surrogate for 
fracture risk and skeletal integrity in 
astronauts may incur the following risks:
1. Restricting our understanding spaceflight effects on hip and spine 
integrity
2. Inadequately evaluating efficacy of countermeasures
3. Failing to identify astronauts at greater risk (both during and after 
spaceflight)
4. Subsequently failing to provide greater protection against risk
Hence, Bone Research is taking the following Path to Risk Reduction:
Age (yr)
Age-related Loss
Menopause-induced Loss
Peak Bone Mass
Females
Males
Bone mass
(g/calcium)
Riggs BL, Melton LJ:  Adapted from Involutional osteoporosis
Oxford Textbook of Geriatric Medicine
ADAPTED SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
Overloading during OPS
Fracture Risk during Mission Operations [OPS]: Collecting new bone data to estimate 
bone strength and inform NASA’s PRA module  for Applied Loads > Bone Strength
Age (yr)
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Riggs BL, Melton LJ:  Adapted from Involutional osteoporosis
Oxford Textbook of Geriatric Medicine
ADAPTED SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
Fracture Risk during Long-term Health [LTH] : a) Monitor for persistent space-induced 
changes (clinical trigger at R + 2 years) and b) Develop new FE strength-based bands of 
bone health based upon predicted fractures for advanced ages.
LTH
*Osteoporosis due to changes due to aging.
Age (yr)
Age-related Loss
Menopause-induced Loss
Peak Bone Mass
Females
Males
Bone mass
(g/calcium)
Riggs BL, Melton LJ:  Adapted from Involutional osteoporosis
Oxford Textbook of Geriatric Medicine
ADAPTED SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
Overloading due to preflight activities 
performed on reduced bone strength.
Fracture Risk soon after return to Earth: Explore a Factor of Risk (Applied 
load/bone strength) to inform astronauts about potential hazardous conditions?*
*Counseling the “athlete vs. the office worker”?
Questions
Thanks for your attention.
Backup Slides
Path to Risk Reduction – what is Essential vs. Good-to-Know?
Optimize risk definition by end of ISS platform. (2020-2024)
Focus on risk factors that are modifiable.
(*) Risk Custodian: J. Sibonga
e.g., Radiation
FEM + BMD
FEM + BMD
Hip QCT,  Back, 
Microarchitecture
FEM + BMD
Epidemiology
FEM + BMD
Research for CPGs
PRA for LTH
CPGs – clinical practice guidelines
PRA=probabilistic Risk Assessment
LTH = Long term Health
FEM = Finite Element Models/Modeling
BMD=bone mineral density; QCT = quantitative computed tomography
FEM + BMDe.g., Digital 
Astronaut
Current Status 
Supplementary One-Pager Information
If Applicable – Add slides as necessaryHuman System Risks – Proposed Likelihood vs Consequence
Low
<0.1 %
High
>1.0%
Mission Health and Performance (OPS)
Minor injury/illness that is self-limiting
OR
Minor impact to performance and operations-
requires additional resources (time, consumables)
Likelihood
Consequence
Quality of Life is defined as impact on 
day to day physical and mental functional 
capability and/or lifetime loss of years
• Return to baseline values within 1 
year with nominal intervention 
(time, exercise, nutrition, lenses)
• Negligible effect on quality of life
Temporary discomfort
OR
Insignificant impact to performance and 
operations - no additional resources required
• Return to baseline values within 3 
months with limited intervention
• No effect on the quality of life
Significant injury, illness, or incapacitation  –
may affect personal safety
OR
Significant reduction in performance results in 
the loss of some mission objectives
• Return to near baseline requires 
extended medical intervention w/
known clinical methods/technologies
(pharmaceuticals, etc.)
• Moderate impact on quality of life 
Death or permanently disabling injury to one or 
more crew (LOC) 
OR
Severe reduction of performance that results in 
loss of most mission objectives (LOM)
• Unknown and improbable return to 
baseline (requires drastic 
intervention surgery & therapy)
• Major impact on quality of life 
(permanent reduced function, 
premature death)
Long Term Health (post mission) (LTH)
2 x 1
2 x 2
2 x 3 
2 x 4
Consequence
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Medium
<1 %
1 x 1
1 x 2
1 x 3
1 x 4
3 x 1
3 x 2
3 x 3 
3 x 4
CM = Countermeasure
LOC = Loss of Crew
LOM = Loss of Mission
Do not delete this slide – may be needed for discussion at the HSRB
“Mega-analysis” for Fracture Prediction
Constraint: “Fracture Prediction” requires large # subjects. 
~60,000 subjects ~250,000 person-years 
~5,400 total fractures ~ 3,500 OP fractures 
~1,000 hip fractures
• Rotterdam
• EVOS/EPOS
• CaMos
• Rochester
• Sheffield
• Dubbo
• EPIDOS
• OFELY
• Kuopio
• Hiroshima
• Gothenburg 1
• Gothenburg 2
Cohorts analyzed but not merged: MEDOS, NHANES, Asia
Possible future cohorts: OFELY extension, OPUS, SOF
Adapted, Slide courtesy of S. Petak, M.D.
Adapted from: Pathogenesis of Osteoporosis-Related Fractures (NOF) Cooper C, Melton LJ
Fracture
Probability
Aging
Hypogonadism
and
Menopause
Excessive 
bone 
loading
Clinical risk factors
High bone 
turnover
Inadequate 
peak bone 
mass
Increased 
bone loss
Falls
Skeletal 
fragility
Impaired 
bone quality
Propensity 
to fall
Fall 
mechanics
Certain 
activities
Low bone 
density
Background: Bone is a complicated tissue.  Clinical 
assessment evaluates multifactorial nature of bone loss and 
fracture risk.*
Lifestyle factors
Genetic factors
Medications
Disorders
 Androgen insensitivity
 Anorexia ervosa and bulemia
 Athletic amnorrhea
 Hyperpr l ctinemia
 Panhypopituitarism
 Cystic fibrosis
 Osteogenesis imperfecta
 Marfan syndrome
 Hemochromato is
 Riley-Day syndrome
 Low calcium intake
 Alcohol (3 or more drinks/d)
 Smoking
 High salt intake
 Immobilization/Reduced physical 
activity 
 Endocrinal
 Gastrointestinal
 Hematologic
 Rheumatic and autoimmunal
 Miscellaneous
 Anticoagulants
 Anticonvulsants
 Barbiturates
 Glucocorticoids
 Cancer chemotherapeutic drugs
* Presented cohort trends and 
individual case reports in closed 
meeting.
Adapted from: Pathogenesis of Osteoporosis-Related Fractures (NOF) Cooper C, Melton LJ
Fracture
Probability
Aging
Hypogonadism
and
Menopause
Excessive 
bone 
loading
Ca/Nutrition/
Vit D/Endocrine 
Perturbations/
Muscle Atrophy
Unbalanced and 
increased bone 
resorption
Inadequate 
peak bone 
mass
Increased 
bone loss
Falling in partial
gravity
Skeletal 
fragility
Impaired 
bone quality
Postural
instability/
Gait impairment
Fall 
Mechanics in hypoG
Hazardous environment/
Kinetic energy
Certain 
Activities
Extravehicular
Activities
Exercise loading
Low bone 
density
Bone loss in space is novel: Operationally-induced* factors in 
astronauts are possible contributors to fracture risk. 
Reduced  activity, 
weightbearing; diet
Family History
Medications
Disorders
CO2; Radiation on bone marrow cells, 
Fluid shifts and regional blood flow
*exposure to space environment and mission operations
Constraint: Astronauts are understudied population-
very limited baseline knowledge (1/2015).
• Typical space mission duration – 160 ± 32d (range 49-215d)
• Average Age – 47 ± 5 y (range 36 – 56)
• Male to Female Ratio – 4.7 : 1 (56:12)
• Current total # per astronauts in corps – 68 of 365
• # repeat fliers – 7
• BMI – Male BMI 25.7 ± 2.2 (range 21.2 to 30.7) Female BMI 22.3 ±
2.3 (range 20.1 to 25.9) 
• Wt and Ht- Males: Males: 82 ± 9 (63 to 103); 177 ± 6 (163 to 188) 
Females : 65 ± 7 (54 to 81), 169 ± 4 (163 to 178)
• % Body Fat: Males:  23 ± 4 (14 to 31)  Females:  29 ± 6 (22 to 44)
FINITE
ELEMENT
STRENGTH
BMD
Geometry
Material 
Properties
Loading
Individualized
Fracture Risk
Which is better? 
Fracture risk assessment by 1 measurement or by > 1 measurement?  
It’s not complicated.
Bone 
Strength
Surrogate
aBMD
Relative 
Fracture Risk
Reported “Disconnects” and Limitations of DXA 
BMD (Slide from 2007)
1. Riggs BL et al.  Effect of fluoride treatment on the fracture rate in postmenopausal 
women with osteoporosis.  N Engl J Med 322(12):802-809, 1990.
2. Riggs BL et al.  Clinical trial of fluoride therapy in postmenopausal osteoporotic 
women:  extended observations and additional analysis.  J Bone Miner Res.  
9(2):265-275, 1994.
3. Cummings SR et al.  Effect of alendronate on risk of fracture in women with low 
bone density but without vertebral fractures:  results from the Fracture 
Intervention Trial.  JAMA 1998  280(24):2119-2120.
4. Gutteridge DH et al.  A randomized trial of sodium fluoride (60 mg) +/- estrogen in 
postmenopausal osteoporotic vertebral fractures: increased vertebral fractures 
and peripheral bone loss with sodium fluoride; concurrent estrogen prevents 
peripheral loss, but not vertebral fractures.  Osteoporosis Int 13(2):158-170, 2002.  
5. Black DM et al.   The effects of parathyroid hormone and alendronate alone or in 
combination in postmenopausal osteoporosis.  N Engl J Med  349(13):1207-1215, 
2003.  (DXA does not pick up significant impact of PTH detected by QCT.)
6. Chesnut CH et al.  Effects of salmon calcitonin on trabecular microarchitecture as 
determined by magnetic resonance imaging: results from the QUEST study.  J Bone 
Miner Res. 2005 Sep;20(9):1548-61.
* Updated data since 2010 Bone Summit
Note: No population data  linking % BMD loss to Fracture 
Outcome
Effects of exercise regimens described using DXA BMD
Journal of Bone & Mineral 
June 28(6):1243-1255, 2013
“Bone Summit I – 2010”
“Bottom Line” Bone Summit II (2013)
“ Overall, NASA’s strategy of assessing relative fracture risk in 
astronauts by T-score BMD-based guidelines alone needs to be 
refined. Accurately determining the absolute fracture risk in 
astronauts is an ambitious goal that may never be fully 
realized. A concerted effort however should be made to 
expand NASA’s technical and scientific capabilities toward 
objectively assessing the factors contributing to the risk since 
long-duration space flight is expected to: 
i) have profound and possibly irreversible bone changes that 
would not be adequately addressed by DXA BMD, ii) affect 
other physiological systems (e.g., muscle) that determine 
fracture likelihood and
iii) expose astronauts to novel situations that involve a greater 
probability of overloading bones.”
Calcium-regulating Hormones – Endocrine 
system is “normal” but perturbed.
Nutrition SMO, unpublished data; Courtesy Dr. SM Smith
QCT critical for detecting countermeasure effects on different 
compartments of bone (cortical vs. trabecular BMDs)
NASA is an engineering agency in the business of space exploration –
i.e., extending human capabilities in space.
Human Research Program - an R & D for NASA - reducing risks to Human System.
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